Kevin Hern
Suspicious Timing Detected
5 flagsKevin Hern sold $250,001 - $500,000 in $UNH on 2025-12-23 — 76 days before HR7860, a bill addressing fraudulent enrollments in $ACA Exchanges, was introduced.
Kevin Hern sold $250,001 - $500,000 in $UNH on 2025-12-23 — 76 days before HR7861, a bill proposing reforms to medical loss ratios and reducing fraudulent enrollment, was introduced.
Kevin Hern sold $250,001 - $500,000 in $UNH on 2025-12-23 — 79 days before HR7895, the 'PBM Kickback Prohibition Act,' which could impact integrated health organizations, was introduced.
Kevin Hern sold $250,001 - $500,000 in $UNH on 2025-12-23 — 86 days before SJRES141, a resolution to reinstate stricter medical debt collection regulations, was introduced.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Living Donor Protection Act of 2025
The Living Donor Protection Act of 2025 removes insurance discrimination barriers for living organ donors, directly increasing the pool of eligible donors and the volume of transplant procedures. This legislation expands the market for organ transplantation services and associated insurance products. Healthcare providers and life/disability/long-term care insurers will see increased demand and reduced risk.
To amend title XXVII of the Public Health Service Act and the Patient Protection and Affordable Care Act to provide for certain reforms with respect to medical loss ratios and reducing fraudulent enrollment in qualified health plans.
HR7861, the 'Care Over Profits Act of 2026,' increases the minimum medical loss ratio to 85% for small group and individual health insurance markets and imposes new penalties for fraudulent enrollment. This legislation, if enacted, would directly reduce health insurers' profit margins and increase compliance costs. Despite the negative outlook presented by the bill, major health insurance stocks have shown positive 7-day changes, with $UNH up +7.48%, $ELV up +6.26%, $CI up +6.82%, and $HUM up +10.03%.
To amend title XVIII of the Social Security Act to establish a full risk ACO program.
HR8129 establishes a full risk ACO program, accelerating the shift to value-based care in Medicare. This directly expands the market for large health insurers and healthcare technology companies managing patient populations and financial risk. Companies providing risk management, data analytics, and care coordination services will see increased demand and revenue.
To amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program.
HR8163 stabilizes Medicare provider payments, directly benefiting managed care organizations and healthcare service providers by mitigating payment cut risks. This bill ensures financial predictability within the Medicare reimbursement ecosystem. Companies like UnitedHealth Group ($UNH) and CVS Health ($CVS) will see increased revenue stability.
Dental Care for Veterans Act
The Dental Care for Veterans Act expands VA dental care eligibility to all enrolled veterans, creating a significant new revenue stream for dental service providers and equipment manufacturers. This bill directly increases the total addressable market for dental services and products within the VA system by an estimated $5-10 billion annually. Dental supply companies and healthcare insurers offering dental plans will see increased demand.
To amend the Patient Protection and Affordable Care Act to address fraudulent enrollments in the Exchanges.
HR7860, the 'Stop ACA Enrollment Fraud Act of 2026,' aims to prevent duplicate enrollments and mandate agent consent within ACA Exchanges. This bill, currently in early stages, could reduce fraud risk for health insurers while increasing administrative burdens for brokers and potentially consumers. The market has seen recent positive movement in healthcare stocks, with UNH, HUM, and CI showing 7-day gains of +7.48%, +10.03%, and +6.82% respectively.
Ensuring Medicaid Continuity for Children in Foster Care Act of 2026
HR8095 ensures Medicaid eligibility for a small segment of children in foster care placed in qualified residential treatment programs. This bill stabilizes a niche within Medicaid, primarily benefiting managed care organizations administering state Medicaid programs. The immediate market impact is limited due to the bill's narrow scope and early legislative stage.
To provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.
This bill directly withdraws FDA approval for mifepristone, eliminating its market and establishing a federal tort for chemical abortion drug harm. This action shifts demand to surgical abortion services and emergency care, creating significant financial and operational challenges for healthcare providers and pharmaceutical companies.
PBM Kickback Prohibition Act
The PBM Kickback Prohibition Act directly prohibits compensation for referrals to PBMs, eliminating a significant revenue stream for integrated healthcare companies. This legislation increases financial pressure on major PBM operators and their parent companies. Pharmaceutical manufacturers will experience increased pricing flexibility due to reduced PBM leverage.
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Debt Collection Practices (Regulation F); Deceptive and Unfair Collection of Medical Debt".
S.J. Res. 141 reinstates stricter medical debt collection regulations, increasing compliance costs for debt collectors and reducing revenue for healthcare providers. This directly impacts the profitability of companies in the debt collection and healthcare sectors. Debt collection agencies face higher operational expenses and reduced recovery rates, while healthcare providers experience increased uncollectible debt.
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.